XOMA
XOMA Royalty CorpCompany Information
- Company Name
- XOMA Royalty Corp
- CIK
- CIK0000791908
- Category
- Non-accelerated filer<br>Smaller reporting company
- Ticker: Exchange
- XOMA: Nasdaq, XOMAO: Nasdaq, XOMAP: Nasdaq
- Fiscal Year End
- December 31
- Owner Organization
- 03 Life Sciences
- SIC
- 2834
- SIC Description
- Pharmaceutical Preparations
- Ticker
- XOMA
SEC filing data through
Insider Sentiment
- Last purchase
- 2025-12-04
- Last sale
- 2025-09-22
- Shares purchased (TTM)
- 116,235
- Shares sold (TTM)
- 933,914
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 16,963,010
- Shares outstanding
- 11,894,000
- Ownership
- 142.62%
Earnings Market Reaction
- Filing date
- 2026-05-12
- Price on filing date
- —
- 1-month reaction
- 0.81%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Series A Preferred Stock | 1 | 1 | 0 | 0 | 1 | 1 | 0 | 0 | 1 | 1 | 0 | 0 | ||||||
| Convertible Preferred Stock | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Series B Preferred Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Assets Current | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 86 | 83 | 45 | 75 | 90 | 102 | 142 | 144 | 136 | 153 | 33 | 31 | ||||||
| Restricted Cash Current | 9 | 5 | 45 | 0 | 1 | 1 | 0 | - | 0 | 0 | - | - | ||||||
| Equity Securities Fv Ni | 0 | 0 | 2 | 9 | 2 | 4 | 1 | 1 | 0 | 0 | 0 | 0 | ||||||
| Accounts And Other Receivables Net Current | 5 | 5 | 4 | 2 | 6 | 2 | 1 | 1 | 0 | 1 | 0 | 1 | ||||||
| Prepaid Expense And Other Assets Current | 0 | 1 | 1 | 1 | 1 | 2 | 2 | 3 | 0 | 0 | 1 | 1 | ||||||
| Assets Current | 119 | 117 | 111 | 105 | 113 | 126 | 159 | 162 | 147 | 169 | 35 | 38 | ||||||
| Restricted Cash Noncurrent | 44 | 45 | 40 | 3 | 3 | 3 | 5 | 6 | 6 | 6 | - | - | ||||||
| Property Plant And Equipment Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Operating Lease Right Of Use Asset | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | 0 | ||||||
| Intangible Assets Net Excluding Goodwill | 44 | 45 | 45 | 45 | 25 | 26 | - | - | - | - | 14 | 15 | ||||||
| Other Assets Noncurrent | 0 | 0 | 1 | 2 | 2 | 2 | 2 | 2 | 1 | 1 | 0 | 0 | ||||||
| Assets | 272 | 273 | 263 | 223 | 213 | 221 | 223 | 243 | 219 | 234 | 124 | 126 | ||||||
Liabilities Current | ||||||||||||||||||
| Accounts Payable Current | 4 | 2 | 3 | 1 | 2 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | ||||||
| Operating Lease Liability Current | 2 | 2 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Deferred Income Current | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | ||||||
| Long Term Debt Current | 14 | 13 | 14 | 12 | 14 | 11 | 10 | 6 | 6 | 6 | - | - | ||||||
| Liabilities Current | 33 | 35 | 28 | 21 | 20 | 24 | 21 | 19 | 16 | 19 | 10 | 7 | ||||||
| Deferred Income Noncurrent | 3 | 3 | 3 | 4 | 4 | 4 | 6 | 6 | 7 | 7 | 8 | 8 | ||||||
| Asset Acquisition Contingent Consideration Liability Noncurrent | 4 | 4 | 4 | 3 | 3 | 3 | 3 | 3 | - | - | - | - | ||||||
| Operating Lease Liability Noncurrent | 20 | 20 | 21 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | - | - | ||||||
| Long Term Debt Noncurrent | 89 | 96 | 94 | 102 | 100 | 107 | 108 | 115 | 115 | 119 | - | - | ||||||
| Deferred Income Tax Liabilities Net | 0 | 0 | 0 | - | - | - | - | - | - | - | - | - | ||||||
| Liabilities | 159 | 169 | 155 | 131 | 128 | 139 | 139 | 143 | 137 | 146 | 18 | 16 | ||||||
| Redeemable Noncontrolling Interest Equity Preferred Carrying Amount | 20 | 20 | 20 | 20 | - | 20 | - | - | - | - | - | - | ||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Additional Paid In Capital | 1,310 | 1,305 | 1,302 | 1,300 | 1,320 | 1,299 | 1,318 | 1,316 | 1,314 | 1,312 | 1,309 | 1,308 | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | - | - | ||||||
| Retained Earnings Accumulated Deficit | -1,217 | -1,221 | -1,214 | -1,228 | -1,235 | -1,237 | -1,233 | -1,216 | -1,232 | -1,223 | -1,203 | -1,198 | ||||||
| Stockholders Equity | 93 | 84 | 88 | 72 | 85 | 62 | 85 | 100 | 82 | 89 | 106 | 110 | ||||||
| Liabilities And Stockholders Equity | 272 | 273 | 263 | 223 | 213 | 221 | 223 | 243 | 219 | 234 | 124 | 126 | ||||||
Temporary Equity Number Of Shares Redemption Value And Other Disclosures | ||||||||||||||||||
| Temporary Equity Par Or Stated Value Per Share | 0.05 | 0.05 | 0.05 | 0.05 | - | 0.05 | - | - | - | - | - | - | ||||||
| Temporary Equity Shares Authorized | 0 | 0 | 0 | 0 | - | 0 | - | - | - | - | - | - | ||||||
| Temporary Equity Shares Issued | 0 | 0 | 0 | 0 | - | 0 | - | - | - | - | - | - | ||||||
| Temporary Equity Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | - | ||||||
Preferred Stock Number Of Shares Par Value And Other Disclosures | ||||||||||||||||||
| Preferred Stock Par Or Stated Value Per Share | - | 0.05 | - | - | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | ||||||
| Preferred Stock Shares Authorized | - | - | - | - | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Preferred Stock Dividend Rate Percentage | 0 | 0 | - | - | 0 | 0 | - | - | 0 | 0 | - | - | ||||||
Common Stock Number Of Shares Par Value And Other Disclosures | ||||||||||||||||||
| Common Stock Par Or Stated Value Per Share | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | ||||||
| Common Stock Shares Authorized | 277 | 277 | 277 | 277 | 277 | 277 | 277 | 277 | 277 | 277 | 277 | 277 | ||||||
| Common Stock Shares Issued | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 11 | 11 | 11 | ||||||
| Shares Outstanding | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 11 | 11 | 11 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialXOMA Royalty Corp (XOMA) — SEC Financial Statements & Analysis
XOMA Royalty Corp (XOMA) is a pharmaceutical preparations company, incorporated in NV. XOMA Royalty Corp trades on Nasdaq as: XOMA, XOMAO, XOMAP. XOMA Royalty Corp (XOMA)'s most recent SEC filing is a Form 10-Q for the period ended 2026-03-31, filed with the SEC on 2026-05-12. Based on that filing, On profitability, XOMA Royalty Corp posts an operating margin of 13.73%, a net margin of 50.42%, a Return on Equity (ROE) of 20.59%, a Return on Assets (ROA) of 7.54%, and a Return on Invested Capital (ROIC) of 6.13%. Per share, it reports EPS of $1.54, diluted EPS of $1.05, free cash flow per share of $-1.17, and a dividend per share of $0.46. Over the trailing year, it posted revenue growth of -15.55% year-over-year, net income growth of -1325.35% year-over-year, and EPS growth of -1333.08% year-over-year. On the balance sheet, it maintains a current ratio of 3.59x, a quick ratio of 3.58x, working capital of $85.67M, a debt-to-equity ratio of 1.71x, a debt ratio of 0.58, an interest coverage ratio of 0.38x, free cash flow of $-13.93M (TTM), and net debt of $-35.91M. Figures sourced from SEC EDGAR.
- EPS TTM
- $1.54
- ROE TTM
- 20.59%
- ROA TTM
- 7.54%
- Debt To Equity
- 1.71x
- Free Cash Flow TTM
- $-13.93M
- Net Revenue TTM Growth 1Y
- -15.55%
Data as of 2026-03-31 · Source: SEC EDGAR
Frequently Asked Questions
What industry is XOMA Royalty Corp in?
XOMA Royalty Corp (XOMA) operates in the Pharmaceutical Preparations industry.
What exchange does XOMA trade on?
XOMA Royalty Corp (XOMA) trades on the Nasdaq.
Where is XOMA Royalty Corp incorporated?
XOMA Royalty Corp is incorporated in NV.
When was XOMA Royalty Corp (XOMA)'s most recent SEC filing?
XOMA Royalty Corp (XOMA)'s most recent SEC filing is a Form 10-Q for the period ended 2026-03-31, filed with the SEC on 2026-05-12.
What is XOMA's EPS (earnings per share)?
XOMA Royalty Corp (XOMA)'s trailing twelve month EPS is $1.54 as of 2026-03-31.
What is XOMA's ROE (return on equity)?
XOMA Royalty Corp (XOMA)'s trailing twelve month Return on Equity (ROE) is 20.59% as of 2026-03-31.
What is XOMA's ROA (return on assets)?
XOMA Royalty Corp (XOMA)'s trailing twelve month Return on Assets (ROA) is 7.54% as of 2026-03-31.
What is XOMA's ROIC (return on invested capital)?
XOMA Royalty Corp (XOMA)'s trailing twelve month Return on Invested Capital (ROIC) is 6.13% as of 2026-03-31.